Star Navigator by Starpharma is your gateway to harnessing the potential of dendrimer technology. Whether you’re reformulating chemotherapeutics to deliver directly to the tumour with minimal systemic exposure, or designing antibody-drug conjugates (ADCs) with high drug-to-antibody ratios (DAR) in a single conjugation step, partnering with Starpharma can open pathways to innovation and new intellectual property.

Our Star Navigator program enables partners across all stages of drug development to licence our dendrimer technology for hands-on experimentation and innovation. Designed to streamline collaboration, this program supports companies and researchers interested in exploring dendrimer applications to enhance their product development or solve delivery challenges.

Early-stage access allows you to evaluate the potential of dendrimer technology in your research with greater speed and flexibility. Explore our library of clinically validated DEP® dendrimers, each equipped with a range of payloads and linkers tailored for targeted drug delivery programs. Dendrimers of different sizes and payload capacities can be "clicked" to your appropriately functionalised targeting motif. This allows you to investigate how increased payload, altered circulation times, and adjusted pharmacokinetics can enhance efficacy and minimise toxicity.

For those seeking additional support, Starpharma offers custom and full-service options from our in-house experts to assist throughout your asset development journey. 

Star Navigator provides efficient access to Starpharma’s dendrimer platform, scientific expertise, and development infrastructure, with the aim of reducing complexity and accelerating progress from concept to execution. 

Starpharma’s DEP® platform is patent protected, and all dendrimers are accessed under a licence or partnership. This ensures that our innovative solutions remain unique and exclusive, giving our partners a competitive edge in the market. 

Basic

This package includes access to a pre-built dendrimer for hands-on experimentation. Our current library focuses on ADC development, including dendrimers loaded with chemotherapeutic payloads, ready to attach to the functionalised targeting group of your program's targeting motif. This could be a viable option if you want to dip your toes into exploring dendrimer applications in your pipeline without the need for our expertise. 

Advanced

This service would allow us to support your asset development with access to our in-house experts in dendrimer technology. We will work with you on possible dendrimer construct modifications, including applications of fit-for-purpose synthetic chemistry techniques. 

Fully Custom

A full-service premium package to support your asset development. This leverages our team's expertise in dendrimer science to its fullest and allows us to act as an extension of your development program with a more hands-on approach.